During atherosclerosis development, miR-155 begins to stimulate atherosclerosis progression through repressing Bcl6 in macrophages, suppressing the expression of eNOS, and increasing pro-inflammatory NF-κB signaling [52]. Here, BCL6 is linked to atherosclerosis.